Clinical Trials Search
Clinical Trial 17799
Study Type: Treatment
Phase of Study: Phase I
- Jimmy Caudell
A Phase I Dose Escalation Trial of Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of the Head and Neck
This study involves another course of radiation (called re-irradiation) to the participant's tumor. The type of radiation is called stereotactic body radiation therapy (SBRT). The purpose of this study is to compare the effects, good and/or bad, of different doses of SBRT given along with the chemotherapy drug, cisplatin. The researchers want to see which dose of radiation will work best in controlling the growth of head/neck cancer. The usual treatment for head/neck cancer that has grown is surgery and/or more radiation with various chemotherapy drugs.
1. Define the maximum tolerated dose (MTD) of SBRT with concurrent cisplatin for reirradiation of locally or regionally recurrent, unresectable head and neck cancer. 2. Secondary objectives include local control, survival, and quality of life.